Stefano Omboni, MD

Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy
Scientific Research Department of Cardiology, Science and Technology Park for Biomedicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation

Prof. Stefano Omboni graduated with distinction in medicine at the University of Milan in 1988 and later specialized in cardiology at the same University in 1992. He is expert in the areas of blood pressure monitoring, telemonitoring, arterial hypertension, cardiovascular disease and telemedicine. His expertise also extends to clinical physiology and pharmacology. He is currently Director of the Italian Institute of Telemedicine, a research center located nearby Varese (Italy), which is dedicated to the research and development of new telemedicine solutions for the prevention and management of chronic diseases, such hypertension, diabetes, asthma, heart failure, and for the prevention of cardiovascular diseases. The center is also involved in technical and clinical studies based on blood pressure monitoring techniques and various diagnostic tools and in the management of clinical and pharmacological trials in different medical specialties. Prof. Omboni is also Chief Researcher at the Scientific Research Department of Cardiology, of the First Moscow State Medical University. Prof. Omboni is member of the Guideline Writing Committee and the Working Group of Blood Pressure Monitoring and Cardiovascular Variability of the Italian and European Society of Hypertension, and member of the Italian, European and International Society of Hypertension, and of the Italian and European Society of Cardiology. He also serves as Editor of some scientific journals and he is member of the editorial board of several international journals. Prof. Omboni has co-authored hundreds of scientific publications and has given lectures in several scientific meetings.

Keywords for research interest: blood pressure monitoring; telemedicine; arterial hypertension, cardiovascular disease; cardiovascular therapy; cardiovascular physiology; clinical pharmacology.

Updated on Oct. 26, 2018